Condition
HPV-Related Vulvar Squamous Cell Carcinoma
Total Trials
5
Recruiting
2
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results
Data Visualizations
Phase Distribution
5Total
P 1 (4)
P 2 (1)
Trial Status
Active Not Recruiting2
Recruiting2
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT05639972Phase 1Recruiting
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
NCT05686226Phase 2Recruiting
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
NCT03260023Phase 1Active Not Recruiting
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
NCT05973487Phase 1Active Not Recruiting
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
NCT06505551Phase 1Not Yet Recruiting
Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma
Showing all 5 trials